Analysis of the tight skin (Tsk1/+) mouse as a model for testing antifibrotic agents
- 1 October 2005
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 85 (10) , 1199-1209
- https://doi.org/10.1038/labinvest.3700331
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Fibulin-2 and Fibulin-5 Alterations in Tsk Mice Associated with Disorganized Hypodermal Elastic Fibers and Skin TetheringJournal of Investigative Dermatology, 2004
- Mutant fibrillin 1 from tight skin mice increases extracellular matrix incorporation of microfibril‐associated glycoprotein 2 and type I collagenArthritis & Rheumatism, 2004
- Polymorphisms of the TGF-?1 Promoter in Tight Skin (TSK) MiceAutoimmunity, 2004
- Fibrillin 1 abnormalities in dermal fibroblast cultures from first‐degree relatives of patients with systemic sclerosis (scleroderma)Arthritis & Rheumatism, 2004
- Role of profibrogenic cytokines secreted by T cells in fibrotic processes in sclerodermaAutoimmunity Reviews, 2002
- Molecular aspects of sclerodermaFrontiers in Bioscience-Landmark, 2002
- Activation of a fibroblast-specific enhancer of the Pro?2(I) collagen gene in tight-skin miceArthritis & Rheumatism, 2001
- Lack of Skin Fibrosis in Tight Skin (TSK) Mice with Targeted Mutation in the Interleukin-4Rα and Transforming Growth Factor-β GenesJournal of Investigative Dermatology, 2001
- Anti-IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of sclerodermaEuropean Journal of Immunology, 1998
- Scleroderma‐like alterations in collagen metabolism occurring in the TSK (tight skin) mouseArthritis & Rheumatism, 1984